Finally, we discuss the potential role of TMAO in CRS and whether TMAO can serve as a biomarker of CRS
Whole blood and plasma samples of six JVC rats were collected at 0.05, 0.167, 0.5, 1, 2, 4, 8, 24, 48, and 72 h after administration (three males and three females at each time point) for the examination of radio pharmacokinetics of total plasma
Crit Rev Biotechnol
Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Studies examining chronic obstructive pulmonary disease (COPD) reveal GHK's ability to reverse pathological gene expression signatures